Luminex Will Be Acquired By DiaSorin For About $1.8Bn
Executive Summary
The buyout will broaden DiaSorin’s positioning in the fast-growing molecular diagnostics space and expand Luminex’s foothold outside the US.
You may also be interested in...
DiaSorin Completes $1.8bn Acquisition Of Luminex
The brokered deal will broaden DiaSorin’s offerings in the rapidly growing liquid diagnostics market, while also providing Luminex furthered access to markets outside of the US.
COVID-19: Nanomix Wins BARDA Funding For Mobile Point-Of-Care Assay
The US government’s Biomedical Advanced Research and Development Authority has awarded Nanomix up to $570,000 to develop a SARS-CoV-2 test for its portable, rapid Nanomix eLab analyzer.
Akili Introduces Adult Version Of Video Game Therapy To Lessen ADHD Symptoms
Video game therapy developer Akili Interactive launched a mobile video game therapy to reduce ADHD symptoms in adults. The company plans to seek FDA clearance.